Colorectal Cancer Clinical Trials in Philadelphia

Showing 221-240 of 259 trials

An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer

NCT00207155

The purpose of this study is to predict response to Erbitux as a single agent in patients with metastatic colon cancer

Eli Lilly and Company110 participantsStarted Dec 2003

Duarte, California, United States • Tampa, Florida, United States • Baltimore, Maryland, United States +11 more locations

COMPLETEDNA< 1 mile

Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer

NCT00450424

RATIONALE: The use of a CD-ROM may help patients with colorectal cancer or a family history of colorectal cancer make informed decisions about undergoing microsatellite instability (MSI) testing. PURPOSE: This randomized clinical trial is studying an educational CD-ROM to see how well it works compared with standard informed consent to assist decision-making about MSI testing in patients with colorectal cancer or a family history of colorectal cancer.

Colorectal CancerHereditary Non-polyposis Colon Cancer

Fox Chase Cancer Center239 participantsStarted Jun 2007

Newark, Delaware, United States • Boston, Massachusetts, United States • Philadelphia, Pennsylvania, United States

An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer

Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer

Colorectal Cancer Trials in Other Cities

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

Irinotecan With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Increasing Colorectal Cancer Screening in African Americans

Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants

Fluorouracil and Leucovorin With or Without Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Oxaliplatin in Treating Patients With Recurrent Metastatic Colorectal Cancer

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

BLI850 vs an Active Control Bowel Preparation in Adult Subjects Undergoing Colonoscopy

Study of Vaginal Dilator Use After Pelvic Radiotherapy

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

Monoclonal Antibody F19 in Treating Patients With Advanced or Metastatic Cancer

A Comparison of Air Insufflation, Water Immersion and Water Exchange Colonoscopy in CRC Screening

Other Conditions in Philadelphia